Atomic Ai

Atomic AI is a biotechnology company specializing in the integration of artificial intelligence and structural biology to advance RNA-based drug discovery. By leveraging their proprietary AI-driven platform, they analyze RNA structures to identify novel therapeutic targets and design innovative RNA-targeting molecules, generating revenue through partnerships, licensing, and drug development. Founded in 2021, the company has gained attention for its cutting-edge approach to RNA therapeutics, which holds potential for treating diseases previously considered undruggable. Their mission emphasizes transforming drug discovery through computational and biological innovation.

Recent Posts by Atomic Ai

1-7 of 7